Amir Abolfathi, CEO

Amir founded Sonitus Medical, Inc. in 2006, leveraging 20 years of experience in founding, building, and managing medical device companies. Prior to Sonitus, Amir served for six years as an Officer, Vice President of R&D at Align Technology Inc. (NASDAQ: ALGN), creators of a unique, invisible orthodontic product. Previously, Amir was the first member of the senior management team at Embolic Protection Inc., where he was a consulting VP of Operations. EPI was successfully acquired by Boston Scientific in 2001. In early 1995, Amir co-founded EndoTex Interventional Systems, developers of minimally invasive solutions for treatment of carotid artery disease, which was also acquired by Boston Scientific in 2006. Amir has also held various management and engineering positions at Pfizer, Guidant, and Baxter-Edwards. As a seasoned entrepreneur, Amir has over 60 issued and pending patent applications, including 11 publications in peer review journals. Amir received his M.S. in Engineering Management from the University of Southern California and a B.S. in Biomedical Engineering from UC San Diego.

Kurt Carlson, Ph.D., J.D.: Vice President of Intellectual Property; Head of National Security Applications

Kurt joined the company as Vice-President of Corporate and IP Strategy. Prior to joining Sonitus, Kurt was an attorney at Wilson Sonsini Goodrich & Rosati representing several biopharmaceutical, diagnostic and medical device companies in the areas of technology transactions and strategic IP counseling. Prior to joining WSGR, Kurt worked for several biotechnology firms in the fields of intellectual property law and business development. His most recent position was as Vice-President, Intellectual Property and Corporate Development, for KineMed, Inc., a privately-held biopharmaceutical company. In addition to his civilian experience, Kurt served in the U.S. Navy Reserve for 21 years, retiring with the rank of Commander. Kurt received his B.A. in Biochemistry from the University of California at San Diego, his M.P.H. and Ph.D. in Pharmacology and Toxicology from the University of California at Berkeley, and his J.D. from the University of San Francisco.

Patrick W. Fabian, Vice President of Sales & Marketing

Mr. Fabian has over 20 years experience in the medical device industry. From August 2007 through November 2010 Mr. Fabian held the position of Senior Vice President of Sales and Training for Acclarent Inc. In January 2007 he was appointed Senior Vice President at Accellent Inc responsible for sales and marketing of a $350 Million dollar business. In 2006 Mr. Fabian held the position of Executive Vice President and General Manager for Accellents Cardiology division as well as Vice President Sales in 2004 – 2005. Prior to joining Accellent, Mr. Fabian was Director of Sales for Smith & Nephew Endoscopy. From 1994 to 2001, Mr. Fabian held various management positions with Tyco, United States Surgical, including Area Director of the Auto Suture business. From 1991 to 1994, Mr. Fabian served as a Territory Manager for Pfizer Inc. Mr. Fabian has a B.A. in Business Administration from The University of St. Thomas (1991).

Mike Favet, COO

Mike brings over 20 years of medical device industry experience to Sonitus. Prior to joining Sonitus in June 2012, Mike accumulated broad cross-functional experience in medical device companies of various sizes with products in diverse therapeutic areas. Mike served as Senior Vice President of Science, Technology & Operations for Ventus Medical where he led the R&D;, manufacturing, clinical, quality, regulatory and reimbursement functions for this venture-backed company with a novel device for the treatment of obstructive sleep apnea. While at Ventus, Mike led the organization through several product launches, the completion and publication of 7 clinical studies, and the scaling up of manufacturing to support commercial launch. Mike also held vice president level positions in R&D; and operations in the Cardiac Surgery business units of Guidant, Boston Scientific and Maquet. Additionally, Mike held various positions in the Cardiac Rhythm Management business of Guidant including leadership roles in R&D; and project management as well as roles in field clinical, design and manufacturing engineering. Mike received a Bachelor of Science degree in Mechanical Engineering from the University of Illinois and an MBA from the University of Minnesota.

Peter Hadrovic, Vice President of Business Development; Head, Emerging Business Opportunities

Peter Hadrovic brings to Sonitus broad industry experience in strategy, management, and business transactions, as well as experience in the public sector. Prior to Sonitus, Peter was Senior Vice President, Corporate Development at Adamas Pharmaceuticals, a developer of small molecule controlled release combination drugs. Before Adamas, Peter served as Vice President, Business Development, General Counsel and General Manager of Laserscope, a publically traded medical device company maker of the GreenLight surgical laser, until it was acquired by American Medical Systems. Prior to joining industry, Mr. Hadrovic specialized in general corporate, securities and M&A law at Venture Law Group advising emerging technology companies in Silicon Valley, and before that in M&A and structured finance transactions at White & Case/New York representing Fortune 500 companies. He also brings valuable expertise from the public sector, where he served as a U.S. congressional aide responsible for health care policy, among other issues. Mr. Hadrovic received an A.B. from Princeton University and a J.D. from Cornell Law School.

Jeff Mack, CFO

Jeff joined Sonitus in June 2012 with over 25 years of experience, bringing a strong background with fast-growing, technology-based companies. He has extensive experience in all areas of financial management, including capital events/IPOs, SEC reporting and compliance, M&A; and investor relations. Most recently, he was the CFO of Enobia Pharma Corp., a venture and private equity backed biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders. Enobia was purchased by Alexion Pharmaceutical in February 2012 in an all-cash transaction with a potential value of more than $1 billion. Prior to joining Enobia, Jeff held pivotal roles in successful public offerings and follow-on offerings with several companies. These included cardiovascular device companies Volcano Corporation and Thoratec Corporation, where he served as Vice President, Finance and Corporate Controller. He has also held finance and operations positions with increasing levels of responsibility in a variety of industries, including computer disc drives, resort management and alternative energy. He began his career at Deloitte, Haskins and Sells, a global firm providing auditing, accounting and advisory services. Jeff has a Bachelor of Science degree from California State University, East Bay (formerly Hayward) and is a Certified Public Accountant.

Tim Proulx, Vice President of Research & Development

Tim brings 20 years experience in medical devices and medical imaging to the R&D team at Sonitus. With degrees in biomedical and electrical engineering, Tim has spent most of his career in research and development of advanced diagnostic and therapeutic ultrasound transducers and materials, piezoelectric devices and audio/RF signal processing algorithms. Prior to joining Sonitus, Tim was Director of Systems Development at Cabochon Aesthetics, Inc. which developed a high power ultrasound ablation system for aesthetics procedures. He has also held positions in engineering management and project management at Siemens Medical Solutions (formerly Acuson) and BCTech, Inc. and has considerable experience in medical device regulations and quality systems, including ISO 13485 and IEC 60601 standards. Tim has three issued patents and 10 patents pending, several technical publications and has presented at IEEE UFFC and IHCON technical conferences. Tim is a graduate of Duke University and Stanford University and currently serves on the Duke University BME Undergraduate Advisory Board.

Andreas Sand, Vice President of Systems Engineering

With more than 12 years of experience in technical and people management within the embedded, telecom and medical device industry, Andreas brings broad knowledge and expertise of electronic design, processes, regulatory and people managing to the R&D team. Andreas was previously Director of R&D at Kontron America, where he headed up a design team of 20 people developing extremely miniaturized embedded PC designs as well as providing full custom design services. Andreas has successfully launched more than 15 products into the market space ranging from remote wireless sensors, patient monitor, point of sales terminals, slot machine designs, small office wireless DSL routers, as well as a series of extremely miniaturized embedded PC designs. Andreas has further developed and implemented a strategic turn-around of a previous company recovering from 10 years of losses into a now successful and profitable business unit within Kontron. Andreas is an electrical engineering graduate from Technical University of Denmark and further holds a business degree from Copenhagen Business School.

Kathleen Sorman, Head Director, Reimbursement Strategy and Health Policy

Kathleen joined Sonitus Medical in May 2012, bringing 20+ years of health care experience. Her career in health care began as a Contract Manager for HealthPartners of Minnesota where she developed their first HMO and the first Managed Work Comp networks. From there, she spent close to 8 years with Medtronic in their Neurological division, Reimbursement Strategy group. Here, she supported each of the therapies, including the implantable infusion pump for the treatment of spasticity, pain and cancer pain and stimulation and Deep Brain stimulation therapies for the treatment of pain and Parkinson’s Disease. At Medtronic, she worked with Medicare to achieve and improve payment. Her work also included obtaining codes for payment including CPT, HCPCS and ICD-9-CM procedure codes. In addition, she worked with commercial insurers and provided support to physician practices and facilities to obtain maximum appropriate payment. After leaving Medtronic, Kathleen worked with other medical device companies including early stage startups, established companies, and DMEs. She also supported biologic pharmaceuticals for Astellas Pharmaceuticals. Kathleen has a BA in Management from the College of St. Scholastica and an MBA from the Purdue Krannert School of Business.